Schrodinger (NASDAQ: SDGR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.520 | -0.480 | 0.0400 | ||||
REV | 34.570M | 48.663M | 14.093M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: Change Healthcare (NASDAQ:CHNG), MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX) and Pear Therapeutics (NASDAQ:PEAR).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Thursday, May 5, 2022. The analyst firm set a price target for 34.00 expecting SDGR to rise to within 12 months (a possible 23.41% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $27.55 last updated Today at June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Schrodinger.
Schrodinger’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.